2021 |
03/11 | 300 | 300 | 295 | 297 | 0% | 37,200 | 86億8757万 | -4.19% |
03/10 | 297 | 300 | 294 | 297 | +0.34% | 62,200 | 86億8757万 | -4.5% |
03/09 | 291 | 296 | 286 | 296 | +2.42% | 60,100 | 86億5832万 | -5.13% |
03/08 | 288 | 295 | 287 | 289 | +1.4% | 82,900 | 84億5356万 | -7.67% |
03/05 | 288 | 289 | 280 | 285 | -1.04% | 157,100 | 83億3656万 | -9.52% |
03/04 | 293 | 293 | 285 | 288 | -2.7% | 180,600 | 84億2431万 | -9.15% |
03/03 | 297 | 297 | 293 | 296 | -0.34% | 48,500 | 86億5832万 | -6.92% |
03/02 | 295 | 300 | 293 | 297 | +1.02% | 82,600 | 86億8757万 | -7.19% |
03/01 | 15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
03/01 | 295 | 298 | 293 | 294 | -0.34% | 69,900 | 85億9982万 | -8.41% |
02/26 | 300 | 300 | 293 | 295 | -1.99% | 131,900 | 86億2907万 | -8.39% |
02/25 | 300 | 303 | 300 | 301 | +1.01% | 41,800 | 88億458万 | -6.81% |
02/24 | 301 | 307 | 298 | 298 | -1% | 115,500 | 87億1682万 | -8.02% |
02/22 | 299 | 305 | 299 | 301 | +0.67% | 87,900 | 88億458万 | -7.1% |
02/19 | 309 | 309 | 298 | 299 | -1.97% | 103,500 | 87億4607万 | -8% |
02/18 | 311 | 313 | 305 | 305 | -2.56% | 65,600 | 89億2158万 | -6.15% |
02/17 | 298 | 313 | 298 | 313 | +5.03% | 118,000 | 91億5559万 | -3.4% |
02/16 | 306 | 307 | 297 | 298 | -3.25% | 198,700 | 87億1682万 | -8.02% |
02/15 | 325 | 328 | 307 | 308 | -9.14% | 431,800 | 90億933万 | -4.94% |
02/12 | 15:30 2020年12月期決算短信〔日本基準〕(連結) |
02/12 | 15:30 2020年12月期通期決算説明資料 |
02/12 | 339 | 341 | 331 | 339 | -1.17% | 130,800 | 99億1612万 | +4.95% |
02/10 | 341 | 344 | 331 | 343 | +0.59% | 150,400 | 100億3312万 | +6.85% |
02/09 | 345 | 348 | 340 | 341 | -0.58% | 103,600 | 99億7462万 | +7.23% |
02/08 | 350 | 350 | 339 | 343 | -2% | 209,100 | 100億3312万 | +8.54% |
02/05 | 337 | 350 | 333 | 350 | +5.11% | 239,800 | 102億3788万 | +11.46% |
02/04 | 332 | 336 | 331 | 333 | -0.6% | 56,000 | 97億4061万 | +7.07% |
02/03 | 328 | 338 | 328 | 335 | +0.9% | 123,500 | 97億9911万 | +8.41% |
02/02 | 328 | 332 | 322 | 332 | +1.22% | 48,700 | 97億1136万 | +8.14% |
02/01 | 320 | 328 | 313 | 328 | +1.86% | 80,400 | 95億9436万 | +7.54% |
01/29 | 326 | 333 | 321 | 322 | -2.13% | 125,400 | 94億1885万 | +6.62% |
01/28 | 325 | 331 | 323 | 329 | -0.6% | 73,600 | 96億2361万 | +9.3% |
01/27 | 327 | 333 | 327 | 331 | +0.3% | 71,400 | 96億8211万 | +10.7% |
01/26 | 333 | 335 | 326 | 330 | -1.79% | 124,800 | 96億5286万 | +11.11% |
01/25 | 325 | 336 | 323 | 336 | +3.38% | 197,000 | 98億2836万 | +13.51% |
01/22 | 323 | 325 | 321 | 325 | +0.31% | 83,700 | 95億660万 | +10.54% |
01/21 | 321 | 325 | 320 | 324 | +1.25% | 120,700 | 94億7735万 | +10.58% |
01/20 | 331 | 331 | 318 | 320 | +1.59% | 259,200 | 93億6035万 | +9.59% |
01/20 | 8:45 眼科手術補助剤「DW-1002」のカナダにおける承認取得のお知らせ |
01/19 | 307 | 317 | 306 | 315 | +2.61% | 93,500 | 92億1409万 | +8.25% |
01/18 | 311 | 312 | 300 | 307 | -0.65% | 78,600 | 89億8008万 | +5.5% |
01/15 | 297 | 309 | 297 | 309 | +4.04% | 303,900 | 90億3858万 | +6.55% |
01/14 | 15:30 業績予想の修正に関するお知らせ |
01/14 | 297 | 300 | 296 | 297 | -0.34% | 54,900 | 86億8757万 | +2.41% |
01/13 | 301 | 304 | 298 | 298 | 0% | 79,300 | 87億1682万 | +2.41% |
01/12 | 297 | 301 | 294 | 298 | +1.02% | 158,400 | 87億1682万 | +2.05% |
01/08 | 286 | 296 | 286 | 295 | +2.79% | 105,900 | 86億2907万 | +0.68% |
01/07 | 293 | 293 | 286 | 287 | -1.37% | 71,200 | 83億9506万 | -2.38% |
01/06 | 282 | 292 | 282 | 291 | +3.19% | 103,600 | 85億1207万 | -1.36% |
01/05 | 281 | 286 | 279 | 282 | -1.05% | 95,400 | 82億4881万 | -5.05% |
01/04 | 289 | 289 | 280 | 285 | -1.38% | 118,500 | 83億3656万 | -4.68% |
2020 |
12/30 | 280 | 290 | 280 | 289 | +2.12% | 216,200 | 84億5356万 | -3.99% |
12/29 | 270 | 283 | 269 | 283 | +4.43% | 179,700 | 82億7806万 | -6.29% |
12/28 | 276 | 278 | 268 | 271 | -2.87% | 387,900 | 79億2704万 | -10.86% |
12/25 | 280 | 285 | 278 | 279 | -1.06% | 175,300 | 81億6105万 | -8.82% |
12/24 | 276 | 287 | 275 | 282 | +2.55% | 265,300 | 82億4881万 | -8.44% |
12/23 | 276 | 282 | 275 | 275 | -1.08% | 209,200 | 80億4405万 | -11.29% |
12/22 | 284 | 286 | 278 | 278 | -3.47% | 213,900 | 81億3180万 | -10.9% |
12/21 | 290 | 292 | 285 | 288 | -1.37% | 161,400 | 84億2431万 | -8.28% |
12/18 | 290 | 295 | 286 | 292 | +0.34% | 173,600 | 85億4132万 | -7.3% |
12/17 | 296 | 297 | 290 | 291 | -1.02% | 211,800 | 85億1207万 | -8.2% |
12/16 | 299 | 300 | 292 | 294 | -1.67% | 177,400 | 85億9982万 | -7.55% |
12/15 | 301 | 303 | 298 | 299 | -0.99% | 64,400 | 87億4607万 | -6.27% |
12/14 | 299 | 307 | 297 | 302 | +1.68% | 132,000 | 88億3383万 | -5.63% |
12/11 | 292 | 298 | 292 | 297 | +0.34% | 142,300 | 86億8757万 | -7.48% |
12/10 | 297 | 301 | 296 | 296 | -1.33% | 84,000 | 86億5832万 | -8.07% |
12/09 | 304 | 305 | 295 | 300 | -2.6% | 270,000 | 87億7533万 | -7.41% |
12/08 | 311 | 312 | 303 | 308 | -1.28% | 177,900 | 90億933万 | -4.94% |
12/07 | 320 | 321 | 312 | 312 | -2.19% | 207,200 | 91億2634万 | -4% |
12/04 | 321 | 324 | 318 | 319 | -0.62% | 98,500 | 93億3110万 | -1.85% |
12/03 | 324 | 326 | 320 | 321 | -1.23% | 105,600 | 93億8960万 | -1.53% |
12/02 | 321 | 327 | 321 | 325 | +0.31% | 71,800 | 95億660万 | -0.31% |
12/01 | 324 | 327 | 320 | 324 | -1.22% | 151,800 | 94億7735万 | -0.61% |
11/30 | 15:30 ファシリティ契約に基づく第10回新株予約権(行使価額修正条項付)の行使停止要請通知に関するお知らせ |
11/30 | 331 | 334 | 328 | 328 | -0.91% | 57,000 | 95億9436万 | +0.31% |
11/27 | 327 | 333 | 327 | 331 | +0.61% | 132,600 | 96億8211万 | +1.22% |
11/26 | 331 | 331 | 328 | 329 | 0% | 55,800 | 96億2361万 | +0.61% |
11/25 | 332 | 335 | 327 | 329 | -1.5% | 108,300 | 96億2361万 | +0.3% |
11/24 | 327 | 339 | 326 | 334 | +2.14% | 183,200 | 97億6986万 | +1.83% |
11/20 | 326 | 327 | 323 | 327 | +0.31% | 58,700 | 95億6510万 | -0.61% |
11/19 | 327 | 327 | 321 | 326 | -0.31% | 73,100 | 95億3585万 | -1.21% |
11/18 | 322 | 330 | 320 | 327 | +1.55% | 100,800 | 95億6510万 | -1.21% |
11/17 | 328 | 328 | 321 | 322 | -0.92% | 69,000 | 94億1885万 | -3.01% |
11/16 | 324 | 329 | 322 | 325 | -0.31% | 82,100 | 95億660万 | -2.69% |
11/13 | 321 | 328 | 321 | 326 | -0.61% | 79,800 | 95億3585万 | -2.69% |
11/12 | 15:30 2020年12月期第3四半期決算短信〔日本基準〕(連結) |
11/12 | 326 | 331 | 324 | 328 | +0.31% | 77,900 | 95億9436万 | -2.67% |
11/11 | 323 | 329 | 322 | 327 | +1.24% | 78,500 | 95億6510万 | -3.25% |
11/10 | 328 | 328 | 322 | 323 | -0.62% | 76,100 | 94億4810万 | -4.72% |
11/09 | 331 | 331 | 318 | 325 | +0.62% | 120,300 | 95億660万 | -4.69% |
11/06 | 324 | 330 | 322 | 323 | -0.62% | 93,300 | 94億4810万 | -5.56% |
11/05 | 322 | 329 | 322 | 325 | 0% | 78,200 | 95億660万 | -5.25% |
11/04 | 322 | 329 | 319 | 325 | +2.52% | 130,300 | 95億660万 | -5.52% |
11/02 | 317 | 321 | 313 | 317 | +0.32% | 107,900 | 92億7259万 | -8.12% |
10/30 | 326 | 328 | 315 | 316 | -3.07% | 206,300 | 92億4334万 | -8.93% |
10/29 | 323 | 329 | 321 | 326 | -1.51% | 140,500 | 95億3585万 | -6.32% |
10/28 | 333 | 338 | 326 | 331 | 0% | 101,600 | 96億8211万 | -5.16% |
10/27 | 327 | 335 | 326 | 331 | -0.6% | 153,400 | 96億8211万 | -5.7% |
10/27 | 8:50 神経疼痛治療薬「DW-5LBT」の米国における承認申請受理のお知らせ |
10/26 | 332 | 344 | 332 | 333 | 0% | 123,500 | 97億4061万 | -5.67% |
10/23 | 329 | 334 | 321 | 333 | +1.52% | 164,400 | 97億4061万 | -6.2% |
10/22 | 340 | 340 | 322 | 328 | -3.53% | 324,800 | 95億9436万 | -8.12% |
10/21 | 342 | 344 | 340 | 340 | -0.58% | 120,000 | 90億5083万 | -5.29% |
10/20 | 346 | 349 | 341 | 342 | -1.72% | 135,600 | 91億407万 | -5% |
10/19 | 344 | 351 | 343 | 348 | +0.87% | 70,800 | 92億6379万 | -3.87% |
10/16 | 350 | 352 | 344 | 345 | -1.15% | 141,100 | 91億8393万 | -4.96% |
10/15 | 358 | 358 | 347 | 349 | -3.06% | 279,300 | 92億9041万 | -4.12% |
10/14 | 358 | 364 | 358 | 360 | -0.55% | 90,700 | 95億8323万 | -1.37% |